|
HY-100186-10mg
|
MedChemexpress LLC
|
GSK-2881078 [CAS 1539314-06-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100186-100mg
|
MedChemexpress LLC
|
GSK-2881078 [CAS 1539314-06-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100186-25mg
|
MedChemexpress LLC
|
GSK-2881078 [CAS 1539314-06-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100186-5mg
|
MedChemexpress LLC
|
GSK-2881078 [CAS 1539314-06-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100186-50mg
|
MedChemexpress LLC
|
GSK-2881078 [CAS 1539314-06-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100565-1mg
|
MedChemexpress LLC
|
SGC2085 [CAS 1821908-48-8]
|
|
Cancer-programmed cell death
|
|
|
HY-100565-10mg
|
MedChemexpress LLC
|
SGC2085 [CAS 1821908-48-8]
|
|
Cancer-programmed cell death
|
|
|
HY-100565-100mg
|
MedChemexpress LLC
|
SGC2085 [CAS 1821908-48-8]
|
|
Cancer-programmed cell death
|
|
|
HY-100565-5mg
|
MedChemexpress LLC
|
SGC2085 [CAS 1821908-48-8]
|
|
Cancer-programmed cell death
|
|
|
HY-100565-50mg
|
MedChemexpress LLC
|
SGC2085 [CAS 1821908-48-8]
|
|
Cancer-programmed cell death
|
|
|
HY-100617-10mg
|
MedChemexpress LLC
|
(S)-4CPG [CAS 134052-73-6]
|
|
|
|
|
HY-100669-10mg
|
MedChemexpress LLC
|
Mycro 3 [CAS 944547-46-0]
|
|
Cancer-programmed cell death
|
|
|
HY-100669-100mg
|
MedChemexpress LLC
|
Mycro 3 [CAS 944547-46-0]
|
|
Cancer-programmed cell death
|
|
|
HY-100669-2mg
|
MedChemexpress LLC
|
Mycro 3 [CAS 944547-46-0]
|
|
Cancer-programmed cell death
|
|
|
HY-100669-25mg
|
MedChemexpress LLC
|
Mycro 3 [CAS 944547-46-0]
|
|
Cancer-programmed cell death
|
|
|
HY-100669-5mg
|
MedChemexpress LLC
|
Mycro 3 [CAS 944547-46-0]
|
|
Cancer-programmed cell death
|
|
|
HY-100669-50mg
|
MedChemexpress LLC
|
Mycro 3 [CAS 944547-46-0]
|
|
Cancer-programmed cell death
|
|
|
HY-100817-10mg
|
MedChemexpress LLC
|
Rbin-2 [CAS 2032282-97-4]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-100817-100mg
|
MedChemexpress LLC
|
Rbin-2 [CAS 2032282-97-4]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-100817-25mg
|
MedChemexpress LLC
|
Rbin-2 [CAS 2032282-97-4]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-100817-5mg
|
MedChemexpress LLC
|
Rbin-2 [CAS 2032282-97-4]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-100817-50mg
|
MedChemexpress LLC
|
Rbin-2 [CAS 2032282-97-4]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-100978-10mg
|
MedChemexpress LLC
|
(±)-Hexanoylcarnitine (chloride) [CAS 6920-35-0]
|
|
|
|
|
HY-100978-100mg
|
MedChemexpress LLC
|
(±)-Hexanoylcarnitine (chloride) [CAS 6920-35-0]
|
|
|
|
|
HY-100978-25mg
|
MedChemexpress LLC
|
(±)-Hexanoylcarnitine (chloride) [CAS 6920-35-0]
|
|
|
|
